Conventional wisdom dictates that the older a woman gets, the more danger they face when giving birth for the first time. For a while now, medical doctors have had this opinion as well, which is why women are often encouraged by their physicians to have a baby while still young. However, new research suggests that there may be more to this than previously thought. In fact, it would seem that older first-time mothers are more likely to live longer than their younger counterparts.
The study was conducted by researchers from the University of California San Diego School of Medicine, and they found that mothers who decided to become pregnant for the first time at a later time are more likely to live to be 90 years old or more, MedicalXpress reports. The research was led by Dr. Aladdin Shadyab and he said that they found a correlation between the ages that the mothers gave birth, how many times they gave birth, and how long they lived.
"We found that women who had their first child at age 25 or older were more likely to live to age 90," Dr. Shadyab said. "The findings indicate that women with two to four term pregnancies compared with a single term pregnancy were also more likely to live at least nine decades."
The study looked into 20,000 cases of pregnant women for 21 years. Of those numbers, 54 percent lived to the age of 90, but these findings simply suggest correlation as opposed to definitive proof of anything. There are other various factors that could affect how long these women lived, including lifestyle, diet, and genetics.
In the press release about the findings, Dr. Shadyab clarified that their research does not suggest that women should delay their pregnancy. With age also comes other complications that could result in increased risks when giving birth, including hypertension and diabetes. Rather, it’s simply meant to be an indicator that those who survived older pregnancies may have already been in excellent health, to begin with.


Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
How to support someone who is grieving: five research-backed strategies
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 



